WebApr 3, 2024 · Overall, hearing impairment shows a 5-fold higher risk with cisplatin use. “Ototoxicity can manifest as tinnitus, hearing loss in the high-frequency range (4000 to … WebFeb 26, 2024 · The cisplatin ototoxicity occurs between 23% and 50% in adults and up to 60% in children [4,6]. However, some studies have reported elevated hearing thresholds in up to 100% of cisplatin-treated cancer patients [7,8], while it is estimated to be 63% with aminoglycosides and 6-7% with furosemide . In addition, incidence severity of ototoxic ...
Current Strategies to Combat Cisplatin-Induced Ototoxicity
WebApr 26, 2024 · Cisplatin is a highly effective antineoplastic agent used to treat solid tumors. Unfortunately, the administration of this drug leads to significant side effects, including … WebSep 21, 2024 · Cisplatin and other platinum compounds are essential chemotherapeutic agents for the treatment of many pediatric malignancies. Unfortunately, platinum-based therapies can cause ototoxicity, or... sharlene powers
Cisplatin-associated ototoxicity amongst cervical cancer …
Webcisplatin-alone group, indicating a 48% lower incidence of hearing loss in the cisplatin– sodium thiosulfate group (relative risk, 0.52; 95% confidence interval [CI], 0.33 to 0.81; P=0.002). WebMechanistically, cisplatin ototoxicity is associated with the absence of glutathione (GSH) and the inhibition of glutathione peroxidase (GSH.Px) and glutathione reductase activities because cisplatin can covalently bind to the sulfhydryl groups of anti-oxidant enzymes, causing enzyme inactivation. 2 Increased lipid peroxidation in the cochlea ... WebFeb 14, 2024 · The National Comprehensive Cancer Network (NCCN) has updated clinical practice guidelines for Adolescent and Young Adults (AYA) Oncology to include sodium thiosulfate injection (Pedmark) to aid in mitigating the risk of cisplatin-associated ototoxicity in pediatric patients with localized, non-metastatic solid malignancies. 1 population of hearst ontario